๐ Rivaroxaban is an oral direct Factor Xa inhibitor.
โ
Indicated in non-rheumatic AF with one or more risk factors: previous stroke/TIA, heart failure, age >75, diabetes, or hypertension.
โ ๏ธ Always check the BNF link here for the latest prescribing guidance.
๐ About
- Alternative to warfarin for stroke prevention in non-valvular AF.
- Also used in DVT, PE, and post-operative VTE prophylaxis.
- Convenient fixed dosing, no INR monitoring required.
- Cost: ~ยฃ3/day in the UK ๐ท.
โ๏ธ Mechanism of Action
- Factor Xa normally converts prothrombin โ thrombin โ fibrin clot.
- Rivaroxaban directly inhibits Factor Xa (both free and clot-bound in the prothrombinase complex).
- Half-life ~12 hours, with ~66% renal excretion โ dose adjustments needed in renal impairment.
๐ Indications & Doses
- Non-valvular AF:
- CrCl >50 mL/min โ 20 mg PO OD with evening meal.
- CrCl 15โ50 mL/min โ 15 mg PO OD with evening meal.
- VTE prophylaxis:
- Knee replacement โ 10 mg OD for 2 weeks (start 6โ10h post-op).
- Hip replacement โ 10 mg OD for 5 weeks (start 6โ10h post-op).
- DVT/PE treatment:
- 15 mg BD for 21 days, then 20 mg OD with food.
- Some may continue 15 mg OD for extended prevention.
- ACS (adjunct): 2.5 mg BD, usually for 12 months.
๐ Interactions
- โ Bleeding risk with: Aspirin, P2Y12 inhibitors (clopidogrel, ticagrelor), other anticoagulants, fibrinolytics, NSAIDs.
- Avoid with CYP3A4 inducers: Carbamazepine, Phenytoin, Rifampicin, St. Johnโs wort.
- Avoid with CYP3A4 inhibitors: Ketoconazole, Ritonavir, Clarithromycin, Erythromycin, Fluconazole.
โ ๏ธ Cautions
- Renal impairment (dose-adjust or avoid if severe).
- Liver disease with coagulopathy.
- High falls risk โ weigh up bleeding vs stroke risk.
โ Contraindications
- Active pathological bleeding.
- Recent major surgery (brain, spine, ophthalmic).
- Recent intracranial haemorrhage.
- High-risk lesions (GI ulcers, oesophageal varices, aneurysm, malignant tumours with bleeding risk).
- Severe hypersensitivity reaction.
๐ฅ Side Effects
- Bleeding (most serious) โ GI, intracranial, or soft tissue.
- GI upset: abdominal pain, nausea, constipation, vomiting.
- Neurological: headache, dizziness (sometimes related to anaemia from bleeding).
- Falls โ may worsen risk of traumatic intracranial bleed.
๐ก Clinical Pearls
- No routine INR monitoring, but renal function and haemoglobin must be checked regularly.
- Always assess CHAโDSโ-VASc vs HAS-BLED scores before prescribing.
- Safer than warfarin in most patients, but no easy reversal (andexanet alfa exists but limited availability in UK).
- Counsel patients: ๐ฌ "Take with food, never miss a dose, and report any unexplained bleeding/bruising."